Caribou Biosciences Inc (CRBU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 2,198 | 2,667 | 2,353 | 2,077 | 2,024 |
| Gross Profit | 2,198 | 2,667 | 2,353 | 2,077 | 2,024 |
| Operating Expenses | 31,598 | 50,245 | 45,266 | 40,952 | 40,262 |
| Operating Income | -29,400 | -47,578 | -42,913 | -38,875 | -38,238 |
| Other Income | 1,852 | -6,520 | 2,922 | 3,376 | 3,554 |
| Pre-tax Income | -27,548 | -54,098 | -39,991 | -35,499 | -34,684 |
| Net Income Continuous | -27,548 | -54,098 | -39,991 | -35,490 | -34,684 |
| Net Income | $-27,548 | $-54,098 | $-39,991 | $-35,490 | $-34,684 |
| EPS Basic Total Ops | -0.30 | -0.58 | -0.43 | -0.39 | -0.38 |
| EPS Basic Continuous Ops | -0.30 | -0.58 | -0.43 | -0.39 | -0.38 |
| EPS Diluted Total Ops | -0.30 | -0.58 | -0.43 | -0.39 | -0.38 |
| EPS Diluted Continuous Ops | -0.30 | -0.58 | -0.43 | -0.39 | -0.38 |
| EPS Diluted Before Non-Recurring Items | -0.30 | -0.35 | -0.43 | -0.39 | -0.38 |
| EBITDA(a) | $-29,004 | $-46,704 | $-42,200 | $-38,709 | $-38,284 |